Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05699174 · ClinicalTrials.gov registry record · Phase 3
PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation
A Phase 3 study of Amputation and Infections, sponsored by Major Extremity Trauma Research Consortium.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
- 13
- Study locations
NCT05699174 is a Phase 3 study of Amputation and Infections that is actively recruiting participants, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 250 participants, above the 129-participant average among 65 other Amputation trials with a reported enrollment target (94% higher). The trial reports 13 study locations across 11 states.
The verdict
NCT05699174, a Phase 3 study of Amputation and Infections, is actively recruiting participants, sponsored by Major Extremity Trauma Research Consortium.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
- 13
- Study locations
Study Summary
This is a Phase III clinical randomized control trial to investigate differences between patient with an infected nonunion treated by PO vs. IV antibiotics. The study population will be 250 patients, 18 years or older, being treated for infected nonunion after internal fixation of a fracture with a segmental defect less than one centimeter. Patients will be randomly assigned to either the treatment (group 1) PO antibiotics for 6 weeks or the control group (group 2) IV antibiotics for 6 weeks. The primary hypothesis is that the effectiveness of oral antibiotic therapy is equivalent to traditional intravenous antibiotic therapy for the treatment of infected nonunion after fracture internal fixation, when such therapy is combined with appropriate surgical management. Clinical effectiveness will be measured as the primary outcome as the number of secondary re-admissions related to injury and secondary outcomes of treatment failure (re-infection, nonunion, antibiotic complications) within the first one year of follow-up, as defined by specified criteria and determined by a blinded data assessment panel. In addition, treatment compliance, the cost of treatment, the number of surgeries required, the type and incidence of complications, and the duration of hospitalization will be measured.
Conditions Studied
Interventions
- DRUG Standard of Care PO (oral) antibiotics
- DRUG Standard of Care Intravenous (IV) antibiotics
Study Locations (13)
Maryland
- University of Maryland , MD Department of Orthopaedics - Baltimore
- Sinai Hospital Baltimore - Baltimore
North Carolina
- Atrium Health, Carolinas Medical Center - Charlotte
- Wake Forest University Baptist Medical Center - Winston-Salem
Indiana
- Indiana University - Indianapolis
Minnesota
- Hennepin Health - Minneapolis
New York
- Jamaica Hospital Medical Center - Queens
Oklahoma
- University of Okalahoma College of Medicine - Oklahoma City
Pennsylvania
- Penn State University M.S. Hershey Medical Center - Hershey
Tennessee
- Vanderbilt Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-05-30 |
| Est. Completion | 2027-09-29 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05699174
The ClinicalTrials.gov registry entry for NCT05699174 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 129-participant average among 65 other Amputation trials with a reported enrollment target (94% higher). The listed sponsor is Major Extremity Trauma Research Consortium, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care PO (oral) antibiotics is the first listed.
NCT05699174 reports 13 study locations spanning 11 distinct geographic areas - top geographies include Maryland, North Carolina, Indiana.
Frequently Asked Questions
What is clinical trial NCT05699174 about?
NCT05699174 is a clinical study titled "PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation". This is a Phase III clinical randomized control trial to investigate differences between patient with an infected nonunion treated by PO vs. IV antibiotics. The study population will be 250 patients, 18 years or older, being treated for infected nonunion after internal fixation of a fracture with a ...
What is the current status of trial NCT05699174?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2023-05-30. Estimated completion is 2027-09-29.
What conditions does trial NCT05699174 study?
This clinical trial studies the following conditions: Amputation, Infections, Fracture, Lower Extremity Fracture, Nonunion of Fracture.
What interventions are being tested in trial NCT05699174?
The interventions under investigation include: Standard of Care PO (oral) antibiotics (DRUG), Standard of Care Intravenous (IV) antibiotics (DRUG).
Who is sponsoring clinical trial NCT05699174?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05699174 being conducted?
This trial has 13 study locations across Indiana, Maryland, Minnesota, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees
RECRUITING · Phase 2
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.